Corroborating these data, METTL3 mRNA expression positively correlated with HMGCR, SQLE, and SREBP2 mRNA in our human NAFLD-HCC cohort (Figures 5G and S5D). This evidence concerns the gene SREBF2 and metabolic dysfunction-associated steatotic liver disease.